| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
2023 Full Year Outlook (Continuing Operations)
| Current | Prior | |||
| GAAP Operating Income/(Loss) | $97 - $112 million | $101 - $116 million | ||
| Adjusted EBITDA | $270 - $285 million | $260 - $275 million | ||
| GAAP Diluted Earnings/(Loss) Per Share from Continuing Operations | $(0.42) - $(0.58) | $(0.33) - $(0.54) | ||
| Adjusted Diluted Earnings/(Loss) Per Share from Continuing Operations | $(0.09) - $(0.25) | $(0.12) - $(0.33) | ||
| Free Cash Flow | $30 - $50 million | $25 - $45 million | ||
| Net Interest Expense | $94 - $95 million | $92 - $95 million | ||
| Account Receivable Securitization Fees | $10 million | $10 million | ||
| Pension Expense (Non-Operating) | $21 - $22 million | $20 - $22 million | ||
| Tax Expense, Excluding Any Unusual Items | $13 - $17 million | $12 - $15 million | ||
| Net Capital Expenditures | $125 - $135 million | $125 - $135 million | ||
| Q3 2023 Outlook (Continuing Operations) | ||||
| GAAP Operating Income | $24 - $31 million | |||
| Adjusted EBITDA | $67 - $74 million | |||
| GAAP Diluted Earnings/(Loss) Per Share from Continuing Operations | $(0.06) - $(0.14) | |||
| Adjusted Diluted Earnings/(Loss) Per Share from Continuing Operations | $0.00 - $(0.07) | |||
Posted In: NVRI
